Previous randomized trials have measured the CMI response to influenza vaccination in older adults according to changes in IFNγ+, CD4+, or CD8+ T cell frequencies (Cowling et al., 2019; Pillet et al., 2019). The gene discussed is CD4; the disease is influenza.